| MKVCX | OAZIX | MKVCX / OAZIX | |
| Total Expense Ratio | 1.71 | 0.76 | 225% |
| Annual Report Gross Expense Ratio | 1.74 | 0.76 | 229% |
| Fund Existence | 6 years | 6 years | - |
| Gain YTD | 11.423 | 2.933 | 389% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.31B | 12.4B | 59% |
| Annual Yield % from dividends | 2.47 | 2.16 | 115% |
| Returns for 1 year | 20.82 | 10.59 | 197% |
| Returns for 3 years | 52.04 | 28.14 | 185% |
| Returns for 5 years | 53.54 | 23.83 | 225% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RSMVX | 13.52 | N/A | N/A |
| William Blair Small-Mid Cap Value R6 | |||
| PAGRX | 158.19 | N/A | N/A |
| Permanent Portfolio Aggressive Growth I | |||
| PNBAX | 30.86 | N/A | N/A |
| Virtus NFJ Large-Cap Value A | |||
| BDHCX | 9.06 | N/A | N/A |
| BlackRock Dynamic High Income Inv C | |||
| JNGLX | 88.37 | -0.69 | -0.77% |
| Janus Henderson Global Life Sciences D | |||